JUISCI

JUISCI is an artificial intelligence company, founded in 2021. It has 1 recorded funding round, most recently a Seed in October 2025.

Your clinical evidence reference

Employees
11–50
Founded
2021
Website
juisci.com
Last Round
SeedOct 2025
Rounds
1

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Every answer traces back to the original publication. Free for healthcare professionals.

Summary

It lists 11–50 employees. Its most recent funding was a Seed round in Oct 2025. Investors include Big Pi Ventures, Ring Capital and Bpifrance.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedOct 2025
EUR 5.5M

Investors

Similar Companies

Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

JUISCI on Indexed.vc
<a href="https://indexed.vc/companies/juisci"><img src="https://indexed.vc/api/badge/company/juisci" alt="JUISCI on Indexed.vc" width="260" height="76" /></a>